CAS: 153322-05-5 - Lanicemine
Formula:C13H14N2
InChI:InChI=1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2/t13-/m0/s1
InChI key:InChIKey=FWUQWDCOOWEXRY-ZDUSSCGKSA-N
SMILES:N=1C=CC=CC1CC(N)C=2C=CC=CC2
- Synonyms:
- (αS)-α-Phenyl-2-pyridineethanamine
- FPL 15896
- 2-Pyridineethanamine, α-phenyl-, (S)-
- 2-Pyridineethanamine, α-phenyl-, (αS)-
- ARL 15896
Ref: 4Z-L-174003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-L-174001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Lanicemine-d5
Controlled ProductCAS:153322-05-5
Applications Lanicemine-d5 is the isotope labelled analog of Lanicemine (L173950); a non-selective voltage-dependant NMDA channel …
Formula:
C13D5H9N2
Color and Shape:
Neat
Molecular weight:
203.294
Ref: TR-L173952
1mg | 196.00 € | ||
5mg | 855.00 € | ||
10mg | 1,479.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Lanicemine
Controlled ProductCAS:153322-05-5
Applications Lanicemine is a non-selective voltage-dependant NMDA channel blocker. It is a potential anti-depressant which …
Formula:
C13H14N2
Color and Shape:
Neat
Molecular weight:
198.264
Ref: TR-L173950
50mg | 494.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Lanicemine-d5
CAS:153322-05-5
Lanicemine is a drug that acts as an NMDA receptor antagonist. It has been shown …
Formula:
C13H9D5N2
Purity:
Min. 95%
Molecular weight:
203.29 g/mol
Ref: 3D-DGA32205
25mg | 362.00 € | ||
250mg | 1,441.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Lanicemine
CAS:153322-05-5
Lanicemine is a low-trapping NMDA channel blocker. It also has a binding (Ki: 0.56-2.1 μM).
Formula:
C13H14N2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
198.26
Ref: TM-T15706
10mg | 226.00 € | ||
25mg | 418.00 € | ||
50mg | 712.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025